Patents by Inventor Ian Paul Conn

Ian Paul Conn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dispersible Tablet Formulations Comprising Dolutegravir
    Publication number: 20230285307
    Abstract: The present invention relates to formulations comprising dolutegravir or a pharmaceutically acceptable salt thereof, processes for making such formulations, and the use of such formulations in the treatment of HIV infection, in particular in the treatment of HIV infection in pediatric patients.
    Type: Application
    Filed: June 23, 2021
    Publication date: September 14, 2023
    Applicant: ViiV Healthcare Company
    Inventors: Ian Paul CONN, Mark Robert DAVIES, Joanne HEAFIELD, Michael HOLTON, Neil MORTIMER
  • Formulations
    Publication number: 20230233470
    Abstract: The present invention relates to formulations comprising dolutegravir or a pharmaceutically acceptable salt thereof, abacavir or a pharmaceutically acceptable salt thereof and lamivudine, processes for making such formulations, and the use of such formulations in the treatment of HIV infection, in particular in the treatment of HIV infection in pediatric patients.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Applicant: ViiV Healthcare Company
    Inventors: Ian Paul CONN, Mark Robert DAVIES, Jose Maria FUEYO, Joanne HEAFIELD, Trevor Martin SHREEVES
  • NOVEL DOSAGE FORM
    Publication number: 20110020447
    Abstract: The present invention relates to a novel dosage form, to a process for preparing the dosage form and to the use of the dosage form in the treatment of neurological and psychiatric disorders.
    Type: Application
    Filed: February 28, 2008
    Publication date: January 27, 2011
    Inventors: Allan James Clarke, Ian Paul Conn, Simon Richard Hicks, Yu Li, Xiaolei Wang